{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:12:56Z","timestamp":1792800776573,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["OPUS 14 2017\/27\/B\/NZ6\/01990"],"award-info":[{"award-number":["OPUS 14 2017\/27\/B\/NZ6\/01990"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["OPUS 14 2017\/27\/B\/NZ6\/01990"],"award-info":[{"award-number":["OPUS 14 2017\/27\/B\/NZ6\/01990"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["OPUS 14 2017\/27\/B\/NZ6\/01990"],"award-info":[{"award-number":["OPUS 14 2017\/27\/B\/NZ6\/01990"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["OPUS 14 2017\/27\/B\/NZ6\/01990"],"award-info":[{"award-number":["OPUS 14 2017\/27\/B\/NZ6\/01990"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["OPUS 14 2017\/27\/B\/NZ6\/01990"],"award-info":[{"award-number":["OPUS 14 2017\/27\/B\/NZ6\/01990"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["OPUS 14 2017\/27\/B\/NZ6\/01990"],"award-info":[{"award-number":["OPUS 14 2017\/27\/B\/NZ6\/01990"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["OPUS 14 2017\/27\/B\/NZ6\/01990"],"award-info":[{"award-number":["OPUS 14 2017\/27\/B\/NZ6\/01990"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["OPUS 14 2017\/27\/B\/NZ6\/01990"],"award-info":[{"award-number":["OPUS 14 2017\/27\/B\/NZ6\/01990"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014434","name":"NAWA","doi-asserted-by":"crossref","award":["BPI\/PST\/2021\/1\/00071\/U\/00001"],"award-info":[{"award-number":["BPI\/PST\/2021\/1\/00071\/U\/00001"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014434","name":"NAWA","doi-asserted-by":"crossref","award":["BPI\/PST\/2021\/1\/00071\/U\/00001"],"award-info":[{"award-number":["BPI\/PST\/2021\/1\/00071\/U\/00001"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014434","name":"NAWA","doi-asserted-by":"crossref","award":["BPI\/PST\/2021\/1\/00071\/U\/00001"],"award-info":[{"award-number":["BPI\/PST\/2021\/1\/00071\/U\/00001"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014434","name":"NAWA","doi-asserted-by":"crossref","award":["BPI\/PST\/2021\/1\/00071\/U\/00001"],"award-info":[{"award-number":["BPI\/PST\/2021\/1\/00071\/U\/00001"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical University of Warsaw","award":["Young Investigator Grant 1WK\/2\/M\/MB\/N\/22\/23"],"award-info":[{"award-number":["Young Investigator Grant 1WK\/2\/M\/MB\/N\/22\/23"]}],"id":[{"id":"https:\/\/ror.org\/04p2y4s44","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02423-5","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:32:18Z","timestamp":1760524338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular cargo of small EVs from NSCLC patient BALF and plasma: unveiling their role in airway inflammation and immune regulation in a novel human 3D bronchial model"],"prefix":"10.1186","volume":"23","author":[{"given":"Magdalena","family":"Dlugolecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Soroczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Homoncik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Polubiec-Kownacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Frankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Wierzbicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannathasan","family":"Thetchinamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Domagala-Kulawik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9169-6194","authenticated-orcid":false,"given":"Malgorzata","family":"Czystowska-Kuzmicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"2423_CR1","unstructured":"International Agency for Research on C. GLOBOCAN. 2022: Global Cancer Observatory. International Agency for Research on Cancer. 2022."},{"issue":"3","key":"2423_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2022","unstructured":"Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17(3):362\u201387.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2423_CR3","first-page":"24","volume":"13","author":"M Nico\u015b","year":"2017","unstructured":"Nico\u015b M, Krawczyk P, Szczyrek M, Mandziuk S, Jarosz B, Wojas-Krawczyk K, et al. Do we apply a personalised lung cancer therapy? Use of molecular tests in scheduling a multilineage treatment in a patient with lung adenocarcinoma. Oncol Clin Pract. 2017;13(1):24\u20139.","journal-title":"Oncol Clin Pract"},{"key":"2423_CR4","doi-asserted-by":"crossref","unstructured":"Kris MG, Johnson BE, Berry LD, Kwiatkowski DJ, Iafrate AJ, Wistuba II, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014;311(19):1998\u20132006.","DOI":"10.1001\/jama.2014.3741"},{"issue":"8","key":"2423_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","volume":"19","author":"AJ Cooper","year":"2022","unstructured":"Cooper AJ, Sequist LV, Lin JJ. Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management. Nat Rev Clin Oncol. 2022;19(8):499\u2013514.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"2423_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/annonc\/mdz077","volume":"30","author":"AJ Schoenfeld","year":"2019","unstructured":"Schoenfeld AJ, Arbour KC, Rizvi H, Iqbal AN, Gadgeel SM, Girshman J, et al. Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib. Ann Oncol. 2019;30(5):839\u201344.","journal-title":"Ann Oncol"},{"key":"2423_CR7","doi-asserted-by":"publisher","first-page":"153303381876345","DOI":"10.1177\/1533033818763450","volume":"17","author":"C Zhang","year":"2018","unstructured":"Zhang C, Ji Q, Yang Y, Li Q, Wang Z. Exosome: function and role in cancer metastasis and drug resistance. Technol Cancer Res Treat. 2018;17:1533033818763450.","journal-title":"Technol Cancer Res Treat"},{"issue":"21","key":"2423_CR8","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1002\/pmic.200900351","volume":"9","author":"S Mathivanan","year":"2009","unstructured":"Mathivanan S, Simpson RJ. ExoCarta:. A compendium of Exosomal proteins and RNA. Proteomics. 2009;9(21):4997\u20135000.","journal-title":"Proteomics"},{"issue":"6","key":"2423_CR9","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.4049\/jimmunol.1101988","volume":"189","author":"L Lugini","year":"2012","unstructured":"Lugini L, Cecchetti S, Huber V, Luciani F, Macchia G, Spadaro F, et al. Immune surveillance properties of human NK cell-derived exosomes. J Immunol. 2012;189(6):2833\u201342.","journal-title":"J Immunol"},{"key":"2423_CR10","doi-asserted-by":"crossref","unstructured":"Soung YH, Ford S, Zhang V, Chung J. Exosomes cancer diagnostics. Cancers (Basel). 2017;9(1):8.","DOI":"10.3390\/cancers9010008"},{"issue":"94","key":"2423_CR11","doi-asserted-by":"publisher","first-page":"14869","DOI":"10.1039\/D0CC06208A","volume":"56","author":"X Zhou","year":"2020","unstructured":"Zhou X, Zhang J, Song Z, Lu S, Yu Y, Tian J, et al. Exotracker: a low-pH-activatable fluorescent probe for labeling exosomes and monitoring endocytosis and trafficking. Chem Commun (Camb). 2020;56(94):14869\u201372.","journal-title":"Chem Commun (Camb)"},{"issue":"2","key":"2423_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ygyno.2011.04.035","volume":"122","author":"AK Rupp","year":"2011","unstructured":"Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, et al. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage. Gynecol Oncol. 2011;122(2):437\u201346.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"2423_CR13","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1097\/JTO.0000000000000282","volume":"9","author":"M Uribarri","year":"2014","unstructured":"Uribarri M, Hormaeche I, Zalacain R, Lopez-Vivanco G, Martinez A, Nagore D, et al. A new biomarker panel in bronchoalveolar lavage for an improved lung cancer diagnosis. J Thorac Oncol. 2014;9(10):1504\u201312.","journal-title":"J Thorac Oncol"},{"issue":"9","key":"2423_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/gcc.22181","volume":"53","author":"M Rodriguez","year":"2014","unstructured":"Rodriguez M, Silva J, Lopez-Alfonso A, Lopez-Muniz MB, Pena C, Dominguez G, et al. Different exosome cargo from plasma\/bronchoalveolar lavage in non-small-cell lung cancer. Genes Chromosomes Cancer. 2014;53(9):713\u201324.","journal-title":"Genes Chromosomes Cancer"},{"key":"2423_CR15","doi-asserted-by":"crossref","unstructured":"Dlugolecka M, Szymanski J, Zareba L, Homoncik Z, Domagala-Kulawik J, Polubiec-Kownacka M, et al. Characterization of extracellular vesicles from Bronchoalveolar lavage fluid and plasma of patients with lung lesions using fluorescence nanoparticle tracking analysis. Cells. 2021;10(12):3473.","DOI":"10.3390\/cells10123473"},{"issue":"8","key":"2423_CR16","doi-asserted-by":"publisher","first-page":"e12257","DOI":"10.1002\/jev2.12257","volume":"11","author":"T Tertel","year":"2022","unstructured":"Tertel T, Tomic S, Dokic J, Radojevic D, Stevanovic D, Ilic N, et al. Serum-derived extracellular vesicles: novel biomarkers reflecting the disease severity of COVID-19 patients. J Extracell Vesicles. 2022;11(8):e12257.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2423_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1587567","volume":"8","author":"A Gorgens","year":"2019","unstructured":"Gorgens A, Bremer M, Ferrer-Tur R, Murke F, Tertel T, Horn PA, et al. Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. J Extracell Vesicles. 2019;8(1):1587567.","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"2423_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/cyto.a.24034","volume":"97","author":"T Tertel","year":"2020","unstructured":"Tertel T, Bremer M, Maire C, Lamszus K, Peine S, Jawad R, et al. High-resolution imaging flow cytometry reveals impact of incubation temperature on labeling of extracellular vesicles with antibodies. Cytometry A. 2020;97(6):602\u20139.","journal-title":"Cytometry A"},{"key":"2423_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/bs.mie.2020.05.013","volume":"645","author":"T Tertel","year":"2020","unstructured":"Tertel T, Gorgens A, Giebel B. Analysis of individual extracellular vesicles by imaging flow cytometry. Methods Enzymol. 2020;645:55\u201378.","journal-title":"Methods Enzymol"},{"key":"2423_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106516","volume":"188","author":"S Mullen","year":"2023","unstructured":"Mullen S, Movia D. The role of extracellular vesicles in non-small-cell lung cancer, the unknowns, and how new approach methodologies can support new knowledge generation in the field. Eur J Pharm Sci. 2023;188:106516.","journal-title":"Eur J Pharm Sci"},{"key":"2423_CR21","doi-asserted-by":"crossref","unstructured":"Lee JS, Hur JY, Kim IA, Kim HJ, Kim WS, Lee KY. Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid from non-small cell lung cancer patients. J Thorac Oncol. 2018;13(10):1051\u201360.","DOI":"10.1016\/j.jtho.2018.08.1116"},{"issue":"5","key":"2423_CR22","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41590-021-00899-0","volume":"22","author":"C Marar","year":"2021","unstructured":"Marar C, Starich B, Wirtz D. Extracellular vesicles in immunomodulation and tumor progression. Nat Immunol. 2021;22(5):560\u201370.","journal-title":"Nat Immunol"},{"key":"2423_CR23","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Sanz J, Mu\u00f1oz-Gonz\u00e1lez N, Cubero JP, Ordo\u00f1ez P, Gil V, Langarita R, et al. Peripheral extracellular vesicles for diagnosis and prognosis of resectable lung cancer: the LUCEx study protocol. J Clin Med. 2025;14(2):411.","DOI":"10.3390\/jcm14020411"},{"key":"2423_CR24","doi-asserted-by":"crossref","unstructured":"Carreca AP, Tinnirello R, Miceli V, Galvano A, Gristina V, Incorvaia L, et al. Extracellular vesicles in lung cancer: implementation in diagnosis and therapeutic perspectives. Cancers (Basel). 2024;16(11):1967.","DOI":"10.3390\/cancers16111967"},{"key":"2423_CR25","doi-asserted-by":"crossref","unstructured":"Pasini L, Ulivi P. Extracellular vesicles in non-small-cell lung cancer: functional role and involvement in resistance to targeted treatment and immunotherapy. Cancers (Basel). 2019;12(1):40.","DOI":"10.3390\/cancers12010040"},{"issue":"3","key":"2423_CR26","first-page":"230","volume":"21","author":"H Zhang","year":"2023","unstructured":"Zhang H, Deng D, Li S, Ren J, Huang W, Liu D, et al. Bronchoalveolar lavage fluid assessment facilitates precision medicine for lung cancer. Cancer Biol Med. 2023;21(3):230\u201351.","journal-title":"Cancer Biol Med"},{"key":"2423_CR27","doi-asserted-by":"publisher","DOI":"10.21037\/pcm-22-46","volume":"6","author":"J Chen","year":"2023","unstructured":"Chen J, Huang S. Extracellular vesicles long RNA for cancer diagnosis and prognosis: a narrative review. Precision Cancer Medicine. 2023;6:13.","journal-title":"Precision Cancer Medicine"},{"key":"2423_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01584","volume":"10","author":"M Zhuo","year":"2020","unstructured":"Zhuo M, An T, Zhang C, Wang Z. Characterization of microbiota in cancerous lung and the contralateral non-cancerous lung within lung cancer patients. Front Oncol. 2020;10:1584.","journal-title":"Front Oncol"},{"key":"2423_CR29","doi-asserted-by":"crossref","unstructured":"Kwiecien I, Skirecki T, Polubiec-Kownacka M, Raniszewska A, Domagala-Kulawik J. Immunophenotype of T cells expressing programmed death-1 and cytotoxic T cell Antigen-4 in early lung cancer: local vs. systemic immune response. Cancers (Basel). 2019;11(4):567.","DOI":"10.3390\/cancers11040567"},{"issue":"2","key":"2423_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00262-016-1930-6","volume":"66","author":"I Kwiecien","year":"2017","unstructured":"Kwiecien I, Stelmaszczyk-Emmel A, Polubiec-Kownacka M, Dziedzic D, Domagala-Kulawik J. Elevated regulatory T cells, surface and intracellular CTLA-4 expression and interleukin-17 in the lung cancer microenvironment in humans. Cancer Immunol Immunother. 2017;66(2):161\u201370.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"2423_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1183\/20734735.001917","volume":"13","author":"J Domagala-Kulawik","year":"2017","unstructured":"Domagala-Kulawik J, Raniszewska A. How to evaluate the immune status of lung cancer patients before immunotherapy. Breathe. 2017;13(4):291\u20136.","journal-title":"Breathe"},{"issue":"4","key":"2423_CR32","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00428-018-2326-0","volume":"472","author":"L Brcic","year":"2018","unstructured":"Brcic L, Stanzer S, Krenbek D, Gruber-Moesenbacher U, Absenger G, Quehenberger F, et al. Immune cell landscape in therapy-naive squamous cell and adenocarcinomas of the lung. Virchows Arch. 2018;472(4):589\u201398.","journal-title":"Virchows Arch"},{"issue":"1","key":"2423_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4049\/jimmunol.182.1.111","volume":"182","author":"Y Han","year":"2009","unstructured":"Han Y, Guo Q, Zhang M, Chen Z, Cao X. CD69\u2009+\u2009CD4\u2009+\u2009CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J Immunol. 2009;182(1):111\u201320.","journal-title":"J Immunol"},{"issue":"3","key":"2423_CR34","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.4049\/jimmunol.1100164","volume":"188","author":"Q Zhao","year":"2012","unstructured":"Zhao Q, Kuang DM, Wu Y, Xiao X, Li XF, Li TJ, et al. Activated CD69\u2009+\u2009T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages. J Immunol. 2012;188(3):1117\u201324.","journal-title":"J Immunol"},{"issue":"1","key":"2423_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93807-3","volume":"11","author":"MF Senosain","year":"2021","unstructured":"Senosain MF, Zou Y, Novitskaya T, Vasiukov G, Balar AB, Rowe DJ, et al. Hla-dr cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior. Sci Rep. 2021;11(1):14424.","journal-title":"Sci Rep"},{"issue":"10","key":"2423_CR36","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.4049\/jimmunol.166.10.6074","volume":"166","author":"S Radoja","year":"2001","unstructured":"Radoja S, Saio M, Frey AB. CD8\u2009+\u2009tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J Immunol. 2001;166(10):6074\u201383.","journal-title":"J Immunol"},{"issue":"3","key":"2423_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017024619","volume":"36","author":"VV Prabhu","year":"2017","unstructured":"Prabhu VV, Devaraj SN. KAI1\/CD82, metastasis suppressor gene as a therapeutic target for non-small-cell lung carcinoma. J Environ Pathol Toxicol Oncol. 2017;36(3):269\u201375.","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"2423_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1336246","volume":"15","author":"K Na","year":"2024","unstructured":"Na K, Lee S, Kim DK, Kim YS, Hwang JY, Kang SS, et al. CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production. Front Immunol. 2024;15:1336246.","journal-title":"Front Immunol"},{"key":"2423_CR39","doi-asserted-by":"publisher","first-page":"6720819","DOI":"10.1155\/2019\/6720819","volume":"2019","author":"R Oba","year":"2019","unstructured":"Oba R, Isomura M, Igarashi A, Nagata K. Circulating CD3(+)HLA-DR(+) extracellular vesicles as a marker for Th1\/Tc1-Type immune responses. J Immunol Res. 2019;2019:6720819.","journal-title":"J Immunol Res"},{"issue":"1","key":"2423_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36863-1","volume":"13","author":"T Leach","year":"2023","unstructured":"Leach T, Gandhi U, Reeves KD, Stumpf K, Okuda K, Marini FC, et al. Development of a novel air-liquid interface airway tissue equivalent model for in vitro respiratory modeling studies. Sci Rep. 2023;13(1):10137.","journal-title":"Sci Rep"},{"key":"2423_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114866","volume":"198","author":"RE Lee","year":"2023","unstructured":"Lee RE, Reidel B, Nelson MR, Macdonald JK, Kesimer M, Randell SH. Air-liquid interface cultures to model drug delivery through the mucociliary epithelial barrier. Adv Drug Deliv Rev. 2023;198:114866.","journal-title":"Adv Drug Deliv Rev"},{"key":"2423_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-9086-3_1","volume":"1940","author":"K Rydell-Tormanen","year":"2019","unstructured":"Rydell-Tormanen K, Johnson JR. The applicability of mouse models to the study of human disease. Methods Mol Biol. 2019;1940:3\u201322.","journal-title":"Methods Mol Biol"},{"key":"2423_CR43","doi-asserted-by":"publisher","first-page":"991991","DOI":"10.3389\/fimmu.2022.991991","volume":"13","author":"E Barreto-Duran","year":"2022","unstructured":"Barreto-Duran E, Szczepanski A, Galuszka-Bulaga A, Surmiak M, Siedlar M, Sanak M, et al. The interplay between the airway epithelium and tissue macrophages during the SARS-CoV-2 infection. Front Immunol. 2022;13:991991.","journal-title":"Front Immunol"},{"issue":"9","key":"2423_CR44","doi-asserted-by":"publisher","first-page":"e0163539","DOI":"10.1371\/journal.pone.0163539","volume":"11","author":"RA Blom","year":"2016","unstructured":"Blom RA, Erni ST, Krempaska K, Schaerer O, van Dijk RM, Amacker M, et al. A triple Co-Culture model of the human respiratory tract to study Immune-Modulatory effects of liposomes and virosomes. PLoS ONE. 2016;11(9):e0163539.","journal-title":"PLoS ONE"},{"issue":"4","key":"2423_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00005-016-0453-3","volume":"65","author":"L Czernek","year":"2017","unstructured":"Czernek L, Duchler M. Functions of cancer-derived extracellular vesicles in immunosuppression. Arch Immunol Ther Exp (Warsz). 2017;65(4):311\u201323.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"2423_CR46","doi-asserted-by":"publisher","first-page":"796385","DOI":"10.3389\/fmolb.2021.796385","volume":"8","author":"Q Bao","year":"2021","unstructured":"Bao Q, Huang Q, Chen Y, Wang Q, Sang R, Wang L, et al. Tumor-Derived extracellular vesicles regulate cancer progression in the tumor microenvironment. Front Mol Biosci. 2021;8:796385.","journal-title":"Front Mol Biosci"},{"key":"2423_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1045624","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Sun J, Dastgheyb RM, Li Z. Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression. Front Immunol. 2022;13:1045624.","journal-title":"Front Immunol"},{"issue":"1","key":"2423_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar MA, Baba SK, Sadida HQ, Marzooqi SA, Jerobin J, Altemani FH, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024;9(1):27.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2423_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06494-z","volume":"15","author":"C Lyu","year":"2024","unstructured":"Lyu C, Sun H, Sun Z, Liu Y, Wang Q. Roles of exosomes in immunotherapy for solid cancers. Cell Death Dis. 2024;15(2):106.","journal-title":"Cell Death Dis"},{"key":"2423_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1023177","volume":"12","author":"B Huang","year":"2022","unstructured":"Huang B, Lang X, Li X. The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Front Oncol. 2022;12:1023177.","journal-title":"Front Oncol"},{"issue":"1","key":"2423_CR51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30(1):36\u201350.","journal-title":"Cell Metab"},{"issue":"1","key":"2423_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10979-3","volume":"10","author":"M Czystowska-Kuzmicz","year":"2019","unstructured":"Czystowska-Kuzmicz M, Sosnowska A, Nowis D, Ramji K, Szajnik M, Chlebowska-Tuz J, et al. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat Commun. 2019;10(1):3000.","journal-title":"Nat Commun"},{"issue":"1","key":"2423_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1956143","volume":"10","author":"A Sosnowska","year":"2021","unstructured":"Sosnowska A, Chlebowska-Tuz J, Matryba P, Pilch Z, Greig A, Wolny A, et al. Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma. Oncoimmunology. 2021;10(1):1956143.","journal-title":"Oncoimmunology"},{"issue":"5","key":"2423_CR54","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/10409238.2013.831024","volume":"48","author":"DG Gamage","year":"2013","unstructured":"Gamage DG, Hendrickson TL. GPI transamidase and GPI anchored proteins: oncogenes and biomarkers for cancer. Crit Rev Biochem Mol Biol. 2013;48(5):446\u201364.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"8","key":"2423_CR55","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/modpathol.2008.76","volume":"21","author":"JK Nagpal","year":"2008","unstructured":"Nagpal JK, Dasgupta S, Jadallah S, Chae YK, Ratovitski EA, Toubaji A, et al. Profiling the expression pattern of GPI transamidase complex subunits in human cancer. Mod Pathol. 2008;21(8):979\u201391.","journal-title":"Mod Pathol"},{"issue":"1","key":"2423_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11759-5","volume":"23","author":"J Xing","year":"2023","unstructured":"Xing J, Gu Y, Song Y, Liu Q, Chen Q, Han P, et al. Myo5a overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma. BMC Cancer. 2023;23(1):1267.","journal-title":"BMC Cancer"},{"issue":"9","key":"2423_CR57","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.1007\/s13277-015-3377-3","volume":"36","author":"B Wang","year":"2015","unstructured":"Wang B, Fang J, Qu L, Cao Z, Zhou J, Deng B. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma. Tumour Biol. 2015;36(9):6901\u20138.","journal-title":"Tumour Biol"},{"key":"2423_CR58","doi-asserted-by":"crossref","unstructured":"Boulter M, Biggar KK. Biological relevance of dual lysine and N-Terminal methyltransferase METTL13. Biomolecules. 2024;14(9):1112.","DOI":"10.3390\/biom14091112"},{"key":"2423_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111216","volume":"120","author":"Y He","year":"2024","unstructured":"He Y, Wang Y, Luo Z, Zhang X, Bai H, Wang J. Smc2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression. Cell Signal. 2024;120:111216.","journal-title":"Cell Signal"},{"issue":"1","key":"2423_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1100-5","volume":"18","author":"L Bian","year":"2019","unstructured":"Bian L, Meng Y, Zhang M, Li D. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment. Mol Cancer. 2019;18(1):169.","journal-title":"Mol Cancer"},{"issue":"9893","key":"2423_CR61","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0140-6736(13)61715-8","volume":"382","author":"R Rosell","year":"2013","unstructured":"Rosell R, Bivona TG, Karachaliou N. Genetics and biomarkers in personalisation of lung cancer treatment. Lancet. 2013;382(9893):720\u201331.","journal-title":"Lancet"},{"issue":"5","key":"2423_CR62","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.cell.2012.10.035","volume":"151","author":"S Huang","year":"2012","unstructured":"Huang S, Holzel M, Knijnenburg T, Schlicker A, Roepman P, McDermott U, et al. MED12 controls the response to multiple cancer drugs through regulation of TGF-beta receptor signaling. Cell. 2012;151(5):937\u201350.","journal-title":"Cell"},{"key":"2423_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-12-28","volume":"12","author":"U Singh","year":"2011","unstructured":"Singh U, Roswall P, Uhrbom L, Westermark B. CGGBP1 regulates cell cycle in cancer cells. BMC Mol Biol. 2011;12:28.","journal-title":"BMC Mol Biol"},{"issue":"2","key":"2423_CR64","first-page":"125","volume":"30","author":"Y Hu","year":"2014","unstructured":"Hu Y, Liao Z, Chen C, Qin N, Zheng J, Tian D, et al. [Over-expressed microRNA-7 inhibits the growth of human lung cancer cells via suppressing CGGBP1 expression]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014;30(2):125\u201330.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"6702","key":"2423_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf1329","volume":"384","author":"D Mathew","year":"2024","unstructured":"Mathew D, Marmarelis ME, Foley C, Bauml JM, Ye D, Ghinnagow R, et al. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Science. 2024;384(6702):eadf1329.","journal-title":"Science"},{"issue":"12","key":"2423_CR66","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1002\/ijc.32624","volume":"145","author":"J Mohrherr","year":"2019","unstructured":"Mohrherr J, Haber M, Breitenecker K, Aigner P, Moritsch S, Voronin V, et al. JAK-STAT Inhibition impairs K-RAS-driven lung adenocarcinoma progression. Int J Cancer. 2019;145(12):3376\u201388.","journal-title":"Int J Cancer"},{"issue":"1","key":"2423_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01742-0","volume":"25","author":"Z Tan","year":"2023","unstructured":"Tan Z, Deme P, Boyapati K, Claes BSR, Duivenvoorden AAM, Heeren RMA, et al. Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer. Breast Cancer Res. 2023;25(1):148.","journal-title":"Breast Cancer Res"},{"key":"2423_CR68","doi-asserted-by":"crossref","unstructured":"Wang R, Zhang L. Identification and functional characterization of essential genes related to gefitinib sensitivity in lung adenocarcinoma. Curr Med Chem. 2024;32(28):3024-5042.","DOI":"10.2174\/0109298673276881240111172756"},{"issue":"9\u201310","key":"2423_CR69","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s10495-023-01861-1","volume":"28","author":"Q Yuan","year":"2023","unstructured":"Yuan Q, Fan Y, Liu Z, Wang X, Jia M, Dong Y, et al. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer. Apoptosis. 2023;28(9\u201310):1315\u201331.","journal-title":"Apoptosis"},{"key":"2423_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155444","volume":"260","author":"R Dahiya","year":"2024","unstructured":"Dahiya R, Sutariya VB, Gupta SV, Pant K, Ali H, Alhadrawi M, et al. Harnessing pyroptosis for lung cancer therapy: the impact of NLRP3 inflammasome activation. Pathol Res Pract. 2024;260:155444.","journal-title":"Pathol Res Pract"},{"issue":"10105","key":"2423_CR71","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ, et al. Effect of interleukin-1beta Inhibition with Canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390(10105):1833\u201342.","journal-title":"Lancet"},{"issue":"11","key":"2423_CR72","first-page":"86","volume":"30","author":"Z Li","year":"2024","unstructured":"Li Z, Yang F, Zhu X, Zhou B, Jin K, Dai J, et al. Effect of NLRP3 inflammasome on lung cancer immune microenvironment activation and its mechanism. Altern Ther Health Med. 2024;30(11):86\u201391.","journal-title":"Altern Ther Health Med"},{"issue":"9","key":"2423_CR73","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41388-021-02156-y","volume":"41","author":"J Mo","year":"2022","unstructured":"Mo J, Moye SL, McKay RM, Le LQ. Neurofibromin and suppression of tumorigenesis: beyond the GAP. Oncogene. 2022;41(9):1235\u201351.","journal-title":"Oncogene"},{"key":"2423_CR74","doi-asserted-by":"crossref","unstructured":"Poole RA, Wang Q, Ray A, Takabe K, Opyrchal M, Katsuta E. Increased PIEZO1 expression is associated with worse clinical outcomes in hormone-receptor-negative breast cancer patients. Cancers (Basel). 2024;16(4):683.","DOI":"10.3390\/cancers16040683"},{"issue":"14","key":"2423_CR75","doi-asserted-by":"publisher","first-page":"286","DOI":"10.14715\/cmb\/2023.69.14.47","volume":"69","author":"X Liu","year":"2023","unstructured":"Liu X, Zeng H, Li Z, Wei C, Zhang Z, Liu X, et al. RNF213 inhibits migration in lung adenocarcinoma cell. Cell Mol Biol (Noisy-le-grand). 2023;69(14):286\u201392.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"2423_CR76","doi-asserted-by":"crossref","unstructured":"Wu Y, Yuan Y, Xu H, Zhang W, Ning A, Li S, et al. Crosstalk among alternative polyadenylation, genetic variants and ubiquitin modification contribute to lung adenocarcinoma risk. Int J Mol Sci. 2024;25(15):8084.","DOI":"10.3390\/ijms25158084"},{"issue":"2","key":"2423_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148911","volume":"11","author":"NS Lui","year":"2016","unstructured":"Lui NS, Yang YW, van Zante A, Buchanan P, Jablons DM, Lemjabbar-Alaoui H. Sulf2 expression is a potential diagnostic and prognostic marker in lung cancer. PLoS ONE. 2016;11(2):e0148911.","journal-title":"PLoS ONE"},{"issue":"5","key":"2423_CR78","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.3934\/mbe.2019231","volume":"16","author":"W Huo","year":"2019","unstructured":"Huo W, Zhu XM, Pan XY, Du M, Sun Z, Li ZM. Microrna-527 inhibits TGF-beta\/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer. Math Biosci Eng. 2019;16(5):4607\u201321.","journal-title":"Math Biosci Eng"},{"issue":"9","key":"2423_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-024-05940-x","volume":"150","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhang H, Yang X, Li S, Wang L, Su H, et al. Myo3b promotes cancer progression in endometrial cancer by mediating the calcium ion-RhoA\/ROCK1 signaling pathway. J Cancer Res Clin Oncol. 2024;150(9):424.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"17","key":"2423_CR80","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.1002\/cam4.4132","volume":"10","author":"L Guo","year":"2021","unstructured":"Guo L, Ding L, Tang J. Identification of a competing endogenous RNA axis SVIL-AS1\/miR-103a\/ICE1 associated with chemoresistance in lung adenocarcinoma by comprehensive bioinformatics analysis. Cancer Med. 2021;10(17):6022\u201334.","journal-title":"Cancer Med"},{"key":"2423_CR81","doi-asserted-by":"crossref","unstructured":"Zhao G, Liu L, Peek RM Jr, Hao X, Polk DB, Li H, et al. Activation of epidermal growth factor receptor in macrophages mediates feedback inhibition of M2 polarization and gastrointestinal tumor cell growth. J Biol Chem. 2016;291(39):20462\u201372.","DOI":"10.1074\/jbc.M116.750182"},{"issue":"6","key":"2423_CR82","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1056\/NEJMoa0808268","volume":"360","author":"J Tol","year":"2009","unstructured":"Tol J, Koopman M, Cats A, Rodenburg CJ, Creemers GJ, Schrama JG, et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med. 2009;360(6):563\u201372.","journal-title":"N Engl J Med"},{"issue":"10","key":"2423_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06194-0","volume":"14","author":"J Shen","year":"2023","unstructured":"Shen J, Liu G, Qi H, Xiang X, Shao J. JMJD5 inhibits lung cancer progression by facilitating EGFR proteasomal degradation. Cell Death Dis. 2023;14(10):657.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2423_CR84","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1158\/1541-7786.MCR-15-0299","volume":"14","author":"K Sossey-Alaoui","year":"2016","unstructured":"Sossey-Alaoui K, Plow EF. Mir-138-mediated regulation of KINDLIN-2 expression modulates sensitivity to chemotherapeutics. Mol Cancer Res. 2016;14(2):228\u201338.","journal-title":"Mol Cancer Res"},{"key":"2423_CR85","doi-asserted-by":"crossref","unstructured":"Zhang H, Zhu X, Friesen TJ, Kwak JW, Pisarenko T, Mekvanich S et al. Annexin A2\/TLR2\/MYD88 pathway induces arginase 1 expression in tumor-associated neutrophils. J Clin Invest. 2022;132(22):e153643.","DOI":"10.1172\/JCI153643"},{"issue":"1","key":"2423_CR86","doi-asserted-by":"publisher","first-page":"e70039","DOI":"10.1002\/jev2.70039","volume":"14","author":"M Holcar","year":"2025","unstructured":"Holcar M, Maric I, Tertel T, Goricar K, Cegovnik Primozic U, Cerne D, et al. Comprehensive phenotyping of extracellular vesicles in plasma of healthy Humans - Insights into cellular origin and biological variation. J Extracell Vesicles. 2025;14(1):e70039.","journal-title":"J Extracell Vesicles"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02423-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:07:34Z","timestamp":1760526454000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02423-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2423"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02423-5","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patients involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and\u00a0approved by the Institutional Bioethical Review Board of the Medical University of Warsaw\u00a0(approval no. KB\/183\/2018, 8 October 2018).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"442"}}